Comparing two drugs Dexmedetomidine and Propofol for anaesthesia in dental procedures
Phase 4
- Conditions
- Health Condition 1: M263- Anomalies of tooth position of fully erupted tooth or teethHealth Condition 2: M274- Other and unspecified cysts of jaw
- Registration Number
- CTRI/2020/04/024683
- Lead Sponsor
- Kasturba Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients undergoing dental OPD procedures requiring conscious sedation
2. Body Mass Index (BMI) less than 30
3. American Society of Anaesthesiologists (ASA) physical status I or II
Exclusion Criteria
1. Patient refusal
2. Clinical history or investigative evidence of ischaemic heart disease, impaired liver, renal function
3. Known allergy to Dexmedetomidine, Propofol or fentanyl
4. Body Mass Index (BMI) more than or equal to 30
5. Patients with difficult airway
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient SatisfactionTimepoint: Patient Satisfaction using Numerical Rating Scale from 0 to 10 assessed at the end of the procedure once the patient is fully awake
- Secondary Outcome Measures
Name Time Method Awareness during procedureTimepoint: Using Modified Brice Questionnaire at the end of the procedure once the patient is fully awake;Episodes of nausea and vomitingTimepoint: numerical value by asking the patient at discharge from the hospital;Time taken for dischargeTimepoint: Using Modified Post Anaesthesia Discharge Scoring System (PADSS) after discontinuation of study drugs at the end of the procedure